Q. Two members of our book group have early signs of cognitive impairment. We have become so close after 10 years of being ...

Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...

Swings in the bond market recently sent the yield on the 10-year Treasury above 4.80% and its highest level since 2023. The ...

Eating healthy and staying active can help keep your brain sharp, but did you know your family's wealth may also affect your ...

Tiktok's future is still uncertain as the app's possible ban is getting closer and closer. Today, the Supreme Court issued ...

Higher consumption of green tea, but not coffee, was associated with fewer cerebral white matter lesions in prospective ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

(WIB) – Millions of older Americans take to the roads daily, driving to doctor’s appointments, grocery stores and social events. However, according to researchers, the healthcare system lacks ...

Lecanemab is approved in the U.S., Japan, China, and several other markets for the treatment of mild cognitive ... (lecanemab) - the world's first drug proven to slow the progression of the disease ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...